Early Access — free while we kick the tires
EdgarHawk

Tobin James P

Director

Director
2 filings analyzed · 1 company · Latest 2025-04-22

Companies

Company Buys Sells Direction
NEOGEN CORP NEOG 2 0 Net buying

Activity

April 2025
2025-04-22 NEOGEN CORP NEOG
medium
Buy
10,000 shares
$47,268
Significance 5/10

Director Tobin James P buys 10,000 shares at $4.73, raising stake 36.4%; stock down 73.2% from $17.71 52-week high, company unprofitable.

James Tobin, a Director, purchased 10,000 shares at $4.73 on 2025-04-22, increasing his holdings from 27,474 to 37,474 shares (+36.4% increase in stake). The purchase occurred while NEOG trades at $4.75, a level -73.2% below its 52-week high of $17.71 and -60.2% over the past 90 days. Fundamentally, the company generated $221.0M in quarterly revenue with +12.4% annual growth, but reported a net loss of $-11.0M and remains unprofitable on a full-year basis. Notably, his same-ticker history at NEOG shows mixed outcomes: a 2024-08-06 buy yielded -14.4% over 90 days, while a 2023-10-12 buy delivered +23.4% over 90 days. A concurrent cluster of 3 other insider purchases within the past 14 days adds a collective pattern dimension to this transaction, though these remain distinct buy decisions.

August 2024
2024-08-07 NEOGEN CORP NEOG
medium
Buy
3,000 shares
$50,571
Significance 6/10

Director James P Tobin bought 3,000 shares of NEOG at $16.86; stock down 31.3% from 52-week high but up 31.8% in 90 days.

Director Tobin James P purchased 3,000 shares at $16.86 on 2024-08-06, representing a 14.7% increase to his holdings and a $50,571.00 commitment. The timing occurs after NEOG has recovered 31.8% over 90 days following a 31.3% decline from its 52-week high of $23.84, placing the entry point in a period of positive momentum. His prior buy at the same ticker on 2023-10-12 achieved a +23.4% 90-day return, establishing a track record of well-timed entry at NEOG. The current purchase follows a similar pattern of buying after material price recovery, though the stock remains 31.3% below its 52-week peak, leaving significant valuation context to assess.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access